Paul J. Pockros MD

Advanced Endoscopic Interventional, Hepatology & Liver Transplantation

Physician

10666 N Torrey Pines RdLa Jolla, CA 92037
Phone+1 858-554-8880
Fax+1 858-554-8150

Dr. Pockros is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pockros' full profile Already have an account?

Education & Training

Scripps Clinic/Scripps Green HospitalFellowship, Gastroenterology, 1982 - 1984
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1978 - 1982
Keck School of Medicine of the University of Southern CaliforniaClass of 1978
University of California, San DiegoB.A., Biology, Magna Cum Laude, 1970 - 1974

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1979 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012, 2014-2017
CMS Meaningful Use Stage 2 Certification MEDSEEK Empower, SymphonyCare, LLC, 2012, 2014-2017
CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2014-2017

Clinical Trials

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy Start of enrollment: 2007 Sep 01
Completed
Phase 2
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network Start of enrollment: 2011 Nov 01
Completed
Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis Start of enrollment: 2013 Aug 01
Completed
Phase 2

Publications & Presentations

PubMed

Regional Comparisons of the Prevalence and Socioeconomics of Hepatitis Delta Virus in Two Southern California Counties.
Kevin Pak, Mei Leng, Jeffrey Nguyen, Karine Moussa, Robert Gish
Journal of Viral Hepatitis. 2026-03-01
1 citations
Lessons From COBALT: Will the Bell Also Toll for Thee?
John Moore Vierling, Paul J Pockros
The American Journal of Gastroenterology. 2025-02-01
Latent Autoimmune Diabetes in Adults (LADA) Occurring in a Patient with Primary Biliary Cholangitis.
Byung K Lee, Kevin Pak, Paul J Pockros
The American Journal of Medicine. 2025-01-01

Journal Articles

A phase 2, randomized, double-blind, placebo-controlled study of maralixibat chloride in the treatment of primary biliary cholangitis associated with itching
Mayo MJ, Pockros PJ, Jones D, et al, Hepatology Communications, 1/1/2019
Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease
Bernstein DE, Tran A, Martin P, Kowdley KV, Bourliere M, Sulkowski MS, Pockros PJ, et al, Kidney Int Rep, 1/1/2019
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients with Hepatitis C Virus Genotype 1 or 4 Infection and Severe Renal Impairment or End-Stage Renal Di...
Lawitz E, Gane E, Cohen E, Vierling J, Agarwal K, Hassanein T, Mantry PS, Pockros PJ, et al, Kidney Int Rep, 1/1/2019

Books/Book Chapters

Controversies in Hepatology: The Experts Analyze Both Sides
Chapter: Should the decompensated Hepatitis C Cirrhotic Be Treated with Antiviral Therapy.
Page 43 - 49Afshar P, Weissman J, Pockros PJEditors: D. Jensen.Slack, Inc.2011
Conn's Current Therapy 2000
Chapter: Cirrhosis.
Page 465 - 471Pockros PEditors: Rakel RE.W.B. Saunders Co., Philadelphia, PA2000
Schiff's Diseases of the Liver
Chapter: Postoperative jaundice.
Page 599 - 605Nyberg LM, Pockros PJEditors: Schiff ER, Sorrell ME, Maddrey WC.Lippincott-Raven Publishers, Philadelphia, PAEdition 8th,1999

Abstracts/Posters

Comparative Diagnostic Performance of the PROMETHEUS (R) FIBROSpect (R) NASH Serum Test with Enhanced Liver Fibrosis (ELF TM) Test for the Identification of Advanced L...
Jain A, Pockros P, Thomas S, et al, NASH-TAG, Park City, UT, 1/3/2019
Three years of Obeticholic Acid (OCA) Therapy Results in Histological Improvements in Patients with Primary Biliary Cholangitis: Further Analysis of the POISE Biopsy S...
Bowlus CL, Pockros P, Kremer AE, et al, GASL 2019 - 35th Annual Conference of the German Association for the Study of the Liver, Berlin, Germany, 1/1/2019
Three years of Obeticholic Acid (OCA) Therapy Results in Histological Improvements in Patients with Primary Biliary Cholangitis: Further Analysis of the POISE Biopsy S...
Bowlus CL, Pockros P, Kremer AE, et al, Canadian Liver Meeting, Montreal, Canada, 1/1/2019

Lectures

What�s Next for PBC?
University of Maryland School of Medicine, Baltimore, MD - 1/1/2019
Update: Hepatitis C Abstracts from AASLD.
Multiple Locations, 2014, 2015, 2016, 2017, 2018 - 1/1/2018
Updates on HBV and HCV (post-EASL Update).
San Diego, CA - 1/1/2018

Other

Direct-acting antivirals for the treatment of hepatitis C virus infection.
Pockros PJ, UpToDate
1/1/2016
Overview of the management of chronic hepatitis C virus infection.
Chopra S, Pockros PJ, UpToDate
1/31/2015
HCV Infection: Update on Diagnosis.
Pockros PJ, Audio-Digest Gastroenterology
1/1/2015

Press Mentions

Pregnant Women, All Adults Should Be Tested for Hepatitis C at Least Once, Experts SayMay 28th, 2021
Future NASH Reimbursement Issues May Echo HCV TherapiesDecember 11th, 2018
Conatus to Host Conference Call Next Week on "Cured" HCV Patients with Residual Liver FibrosisFebruary 12th, 2018

Grant Support

Ribavirin PLUS Infergen For Naive Chronic Hepatitis CNational Center For Research Resources2000–2002
Ribavirin In Chronic Hepatitis C In Comb With PEG InterfNational Center For Research Resources2000–2002
PEG Interferon Alpha 2A For Chronic Hepatitis CNational Center For Research Resources2000–2002
Oral Pantoprazole In Patients With Hepatic ImpairmentNational Center For Research Resources2000–2002
Interferon Alfacon 1in Chronic Hepatitis CNational Center For Research Resources2000–2002